Tb Vaccine
-
{
- All
- News
- Videos
-
Tackling Drug-Resistant Tuberculosis: Johns Hopkins' New Nasal Vaccine Boosts Effect Of Standard Antibiotics
- Sunday July 5, 2026
- Health | Written by Rupashi Chhabra
A new nasal vaccine developed by Johns Hopkins scientists shows promise to tackle drug-resistant tuberculosis. Here are the findings of the study and the implications of the study for India.
-
www.ndtv.com/health
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
- Friday April 17, 2026
- Health | Reported by Pallava Bagla
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
www.ndtv.com/health
-
Bharat Biotech Begins Clinical Trials Of TB Vaccine On Adults In India
- Sunday March 24, 2024
- India News | Press Trust of India
Bharat Biotech International Ltd on Sunday said it started clinical trials of the Tuberculosis vaccine Mtbvac on adults in India.
-
www.ndtv.com
-
New Biomarkers Offer Hope For Effective Tuberculosis Vaccine
- Tuesday April 12, 2016
- Health | Indo-Asian News Service
A team of scientists led by Oxford University has made a discovery that can improve chances of developing an effective vaccine against Tuberculosis (TB).
-
www.ndtv.com/health
-
Tackling Drug-Resistant Tuberculosis: Johns Hopkins' New Nasal Vaccine Boosts Effect Of Standard Antibiotics
- Sunday July 5, 2026
- Health | Written by Rupashi Chhabra
A new nasal vaccine developed by Johns Hopkins scientists shows promise to tackle drug-resistant tuberculosis. Here are the findings of the study and the implications of the study for India.
-
www.ndtv.com/health
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
- Friday April 17, 2026
- Health | Reported by Pallava Bagla
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
www.ndtv.com/health
-
Bharat Biotech Begins Clinical Trials Of TB Vaccine On Adults In India
- Sunday March 24, 2024
- India News | Press Trust of India
Bharat Biotech International Ltd on Sunday said it started clinical trials of the Tuberculosis vaccine Mtbvac on adults in India.
-
www.ndtv.com
-
New Biomarkers Offer Hope For Effective Tuberculosis Vaccine
- Tuesday April 12, 2016
- Health | Indo-Asian News Service
A team of scientists led by Oxford University has made a discovery that can improve chances of developing an effective vaccine against Tuberculosis (TB).
-
www.ndtv.com/health